title: [New Developments in CKD-MBD. Future perspective of calcimimetics].
abstract: Calcimimetics have beneficial effects on not only secondary hyperparathyroidism, but also control of serum calcium and phosphate levels. Development of novel calcimimetics is progressing. Basic studies have demonstrated the direct effect of calcimimetics on the vascular tissues, which may contribute to the improvement of vascular calcification. Further studies are required to evaluate the usefulness of calcimimetics for mortality.
authors.affiliation: Division of nephrology, Department of Medicine, Showa University School of Medicine, Japan.
authors.forename: Masahide
authors.initials: M
authors.lastname: Mizobuchi
authors.forename: Takashi
authors.initials: T
authors.lastname: Inoue
mesh_terms: D040761:Biomimetic Materials / Q000627:therapeutic use*; D001851:Bone Diseases, Metabolic / Q000188:drug therapy* / Q000209:etiology; D002118:Calcium / Q000097:blood; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy / Q000517:prevention & control*; D011379:Prognosis; D051436:Renal Insufficiency, Chronic / Q000150:complications*; D061205:Vascular Calcification / Q000188:drug therapy / Q000517:prevention & control*
chemical_list: D002118:Calcium